• Users Online: 484
  • Print this page
  • Email this page


 
 
Table of Contents
ORIGINAL ARTICLE
Year : 2021  |  Volume : 4  |  Issue : 2  |  Page : 58-63

Topical antibiotic prophylaxis in Lichtenstein hernia repair and comparison of three methods: A prospective randomized clinical trial


1 General Surgery Clinic, University of Health Sciences, Diskapi Yildirim Beyazit Tranining and Research Hospital, Ankara, Turkey
2 Department of General Surgery, Faculty of Medicine, Kastamonu University, Kastamonu, Turkey

Date of Submission24-Jan-2021
Date of Decision14-Feb-2021
Date of Acceptance09-Mar-2021
Date of Web Publication31-May-2021

Correspondence Address:
Prof. Duray Seker
Hilal Mah., 694.Sokak No: 24/10, Cankaya, Ankara
Turkey
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijawhs.ijawhs_6_21

Get Permissions

  Abstract 


INTRODUCTION: Lichtenstein hernia repair is a clean surgical intervention and one of the most frequently applied operation worldwide. Despite guidelines, benefit of antibiotic prophylaxis in hernia surgery has been considered questionable and prophylaxis usage is not infrequent. Here, in this clinical randomized trial, we aimed to compare three different prophylaxis regimens to find out which one is more effective.
METHODS: In this prospective study, patients were divided into three groups. First group (G1) received cefazoline, second group (G2) received topical gentamicin, and third group (G3) received combination of cefazoline and topical gentamicin. On 1st, 7th, and 30th postoperative days, surgical sites were examined for the signs of infection according to the definitions of Centers for Disease Control. Furthermore, effectiveness of infection prevention in patients with comorbid diseases was also analyzed.
RESULTS: Totally 276 patients were analyzed. In G1 three, in G2 two, and in G3 0 infections were recorded. Total, infection rate was 1.8%. There was no any difference in infection rates between three groups (P = 0.285). Comorbidities did not rise infection rates under prophylaxis coverage (P > 0.05).
CONCLUSION: All three methods are equally effective in surgical site infection, but combination method seems better with “0” ratio. Prophlaxy coverage also prevents surgical site infection even in the presence of risk (comorbidities).

Keywords: Anti-bacterial agents, hernia, infection, prevention and control, wounds


How to cite this article:
Seker D, Seker GE, Bayar B, Ergul Z, Kulacoglu H. Topical antibiotic prophylaxis in Lichtenstein hernia repair and comparison of three methods: A prospective randomized clinical trial. Int J Abdom Wall Hernia Surg 2021;4:58-63

How to cite this URL:
Seker D, Seker GE, Bayar B, Ergul Z, Kulacoglu H. Topical antibiotic prophylaxis in Lichtenstein hernia repair and comparison of three methods: A prospective randomized clinical trial. Int J Abdom Wall Hernia Surg [serial online] 2021 [cited 2021 Sep 19];4:58-63. Available from: http://www.herniasurgeryjournal.org/text.asp?2021/4/2/58/317322




  Introduction Top


Open hernia repair with mesh implantation is a clean surgical intervention. It is well documented that antibiotic prophylaxis is needed in selected clean surgical interventions where a prosthesis is implanted. Arthroplasties such as hip or knee replacement and cardiac or vascular graft implants are clean procedures, in which antibiotic prophylaxis has been shown to be beneficial and clearly indicated.[1],[2] However, the benefit of antibiotic prophylaxis in hernia surgery has been considered questionable. Last updated Cochrane meta-analysis concluded that administration of antibiotic prophylaxis for elective inguinal hernia repair cannot be universally recommended.[3] It must be kept in mind that this study includes herniorraphies (with no mesh), hernioplasties (with a mesh), different hernioplasty techniques, and different antibiotics for prophylaxis. In our study, only mesh (a foreign body and potentcial infection cause) repairs were included. European Hernia Society guideline states that “in clinical settings with low rates (<5%) of wound infection, there is no indication for the routine use of antibiotic prophylaxis in elective open inguinal hernia repair in low-risk patients.”[4] Antibiotic prophylaxis is still used for high-risk patients in many centers and in the institutions with high rate of surgical infection. International guidelines for groin hernia repairs, published in 2018, state a significant benefit from antibiotic prophylaxis in a high-risk environment with higher than 5% incidence of wound infection there. Furthermore, there are reports, contrary to guidelines, saying that antibiotic prophylaxis is beneficial to reduce surgical site or deep infection in open hernioplasty.[5],[6],[7],[8] When prophylaxis is needed or preferred as a surgeon's choice, it can be applied intravenously (iv), topically, on in combination. Typical antibiotic prophylaxis for an inguinal hernia repair is the intravenous application of first- or second-generation cephalosporins before skin incision.[8],[9] Topical antibiotic prophylaxis is also a reliable alternative for open inguinal hernia repair.[10],[11] According to the Deysine report, topical gentamicin can help to reach 0 infection rate with the help of a strict aseptic and antiseptic protocol.[11] The presence of these three alternative application methods (iv, topical, and combination) spontaneously emerges the question of “Which method is most effective in preventing or decreasing the postoperative infection?” In this double-blind prospective randomized trial, our objective was to compare the effectiveness of three different antibiotic prophylaxis regimens in a large volume reference hospital.


  Methods Top


This prospective randomized trial was conducted at University of Health Sciences Diskapi Yildirim Beyazit Training and Research Hospital, Ankara, Turkey. The local ethics committees approved the study. All patients gave informed consent. All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008. The trial was registered on http://www.clinicaltrials.gov (NCT01273818).

A sample size of 300 patients (100/group) was calculated. The candidate patients were the ones with primary or recurrent unilateral inguinal hernia who were scheduled for elective open mesh repair during the study period. The patients who underwent contralateral hernia repair previously were also included in the study. Exclusion criteria were age under 18, incarcerated, or strangulated hernias requiring emergency intervention, simultaneous bilateral hernia repair, history of allergic reaction to antibiotics used in the trial, usage of any antibiotic within 1 week before surgery for any reason, and history of any kind of immunosuppressive disease.

All operations were performed by the same group consisting of senior residents and staff surgeons. Skin was shaved just before the operation in the operating room and prepared by povidine-iodine. All patients underwent open hernioplasty using a standard heavy polypropylene mesh (Trulene mesh-sutures, Bangalore, India) in a standardized Lichtenstein technique.

The size of meshes was 10 cm × 15 cm in all groups. In some patients, tailoring of mesh was needed according to the anatomical structures of patients, but in no operation mesh size was smaller than 9 cm × 13 cm. Fixation of mesh was done with polypropylene 2/0 sutures in all groups. Length of skin incision was 9 cm in all groups.

Operation details and distribution of risk factors are given in [Table 1] and [Table 2], respectively.
Table 1: Operative details of the groups

Click here to view
Table 2: Distribution of risk factors among groups

Click here to view


Randomization

Eligible patients were assigned double-blinded randomly to each group. Randomization was done by the use of envelopes which included equal number of patients to be randomized to each arm (G1; IV cefazolin, G2: topical gentamicin, G3: IV cefazolin + topical gentamicin) of the study.

Antibiotic prophylaxis

Patients in G1 group received 1 g cefazolin (cefazolin sodium; Eczacibasi, Istanbul, Turkey) by IV bolus injection. In G2, gentamicin (gentamicin sulfate 80 mg 2%; I, E Ulugay, Istanbul, Turkey) was applied topically to surgical field just after the mesh implantation. In G3, patients received 1 g cefazolin and topical gentamicin. The anesthesiologist administered IV medication when the patient entered the operating room or at least, before the induction of anesthesia. None of the patients in either group was prescribed for any additional antibiotics.

Follow-up and data collection

Patient demographics, comorbid diseases, type of hernia, type of anesthesia, primary versus recurrent hernia, body mass index (BMI), and length of operation were recorded. All patients were discharged on the 1st postoperative day with a prescription of nonsteroidal anti-inflammatory drug. Surgical site dressing was changed in the 1st postoperative day and removed on 3rd postoperative day. Wound was inspected just before discharge and reexamined on 7, 14, and 30 days after surgery. The surgeon who was responsible the follow-up was blinded to the study. None of the visits was performed by telephone interview.

Both deep and superficial infection (infection occurring within 30 days of the operation involving only the skin or subcutaneous tissue) was followed up. Superficial and deep surgical site infection (SSI) was defined according to the latest definition of the Centers for Disease Control.[11] In the presence of seroma or hematoma, aspiration was performed under sterile conditions, and samples were saved for microbial culture. Examination for SSI was done on 1st postoperative day, 7th day, and 30 days after operation.

Outcome

SSI was the primary outcome of this study. Effect of comorbidities on SSI was the secondary outcome.

Statistical analysis

First, we verified that samples from all three groups came from a normally distributed population by Saphiro–Wilk test. To compare data between two independent groups, t-test was used, and to compare data in more than two groups, one-way analysis of variance test was used. To analyze correlation between categorical variables and differences between groups, Chi-squared and Fisher's exact test were used. The results of other demographic and group comparisons were presented as ratio in qualitative variables and as mean and standard deviation in quantitative variables. For the significance of the test, threshold for P value was chosen as 5%. All statistical analyses were done by SPSS 11.5 (Chicago,IL,USA).


  Results Top


A total of 300 patients (100 for each group) were included in this study. During follow-up period, totally 24 patients were excluded due to antibiotic usage for other reasons. For final analysis, data of 98 patients in G1, 87 patients in G2, and 91 patients in G3 (total 276 patients) were used. Flow chart of the study was given in [Figure 1]. Groups were homogenous for age (P = 0.918), sex (P = 0.667), BMI (P = 0.891), length of operation (P = 0.570), primary and recurrent hernia (P = 0.867), hernia type (P = 0.218), and anesthesia type (P = 0.737). Results of the patients in all groups are given in [Table 3]. All patients were discharged in the 1st postoperative day. No adverse effects of the used drugs were recorded. All recorded infections were superficial surgical side infection (SSI) type, no deep infection was recorded. On 1st postoperative day, only one SSI was recorded in G2 group, whereas no infection was observed in other two groups, and this was statistically insignificant (P = 0.334) when compared with other groups. On 7th postoperative day, there were three SSI in G1 group and 1 SSI in G2 group but not statistically significant (P = 0.198). These patients with wound infection were different from the ones who had infection on 1st postoperative day. On 30th postoperative day, no further SSI was recorded in any group. Totally, there were five SSI among 276 patients (1.8%). Three of these five patients were in G1 and 2 in G2 groups. There was no infection in group G3. There was also no significant difference among the three groups when all infections were taken into consideration totally (P = 0.285). In our study, statistical analysis showed that the presence of coexisting diseases (coronary, pulmonary, and endocrine diseases), BMI, anesthesia type, primary, or recurrent hernia type had no effect on SSI development (P = 1.000, 0.637, 0.227, and 1.000, respectively). One patient in G1 developed abscess formation during follow-up, and he was treated successfully with drainage and antibiotic (3rd generation cephalosporins) according to the wound culture and sensitivity test results.
Figure 1: Flow chart of patients participated in the study

Click here to view
Table 3: Results of patients

Click here to view



  Discussion Top


Because of inconsequent evidences, there is no consensus on whether or not antibiotic prophylaxis is effective or not in inguinal hernia repair, but it is obvious that mesh infection is the most challenging early complication both for the health carers and the patient. Recently, Cochrane Collaboration review concluded that usage of antibiotic prophylaxis in inguinal hernia repair was inconclusive.[3] On the other hand, a separate meta-analysis including six of the 11 randomized control trials identified by Cochrane review, it was concluded that antibiotic prophylaxis is beneficial.[5] Furthermore, two other recent meta-analysis support the use of antibiotic prophylaxis in patients undergoing mesh hernioplasty.[12],[13] A previous study of our own center reported no difference in infection between prophylaxis and placebo groups.[14] There is also inconsistency between clinical guidelines: the National Institute of Clinical Excellence (NICE) recommends the use of antibiotic prophylaxis in clean surgery with implanted material but guidelines issued by the Scottish Intercollegiate Guideline Network (SIGN) state that antibiotic prophylaxis is not needed in inguinal hernia repair with or without implanted mesh.[15],[16] Although the European Hernia Guidelines advise that there is no indication for the routine use of antibiotic prophylaxis in elective open or laparoscopic groin hernia repair in low-risk patients but that prophylaxis should be considered for patients with risk factors for wound infection, there seems to be an inconsistency in country-based surgical practices such as conflict between NICE and SIGN guides.[4]

Since there are controversial practices on usage of antibiotic prophylaxis during open prosthetic inguinal hernia surgery in contrary to some other selected clean procedures (like arthroplasties and vascular graft implants) where a prosthesis is implanted, some surgeons are still favoring usage of antibiotic prophylaxis for this procedure. A survey carried out after the publication of these three guidelines; it was observed that, in London (England), only 13% of surgeons do not use any prophylactic regimen in open hernia repair.[17] This is an important report to see that surgeon's beliefs about the effectiveness of antibiotic prophylaxis is more determinative than scientific data. Hence, it seems that usage of any prophylactic agent in open hernia repair with mesh is not infrequent, in addition, there is a group of selected patients (immune-compromised, critically ill, drug users, etc.,), in which prophylaxis is indicated. These realities make surgeons to look forward an effective prophylactic agent. For this reason, we aimed to compare the efficiency of three different prophylaxis agents in this study.

It is generally accepted that prevention of mesh infection is best achieved by usage of systemic antibiotics and topical antibiotics often are used without convincing evidence to support their value. This long established opinion may be because of, when compared, there are very few studies reporting the effectiveness of topical antibiotic application. Favoring the topical prophylaxis or saying that topical way is as effective as intravenous way in hernia repair with mesh seems not heavily supported but in practice reality is not like this. Gentamicin irrigation had been successfully used by neurosurgeons and urologists. Cefazolin and gentamicin were also used with success by surgeons for hernia prophylaxis.[9]

Cefazolin and topical gentamicin are well known and relatively cheap prophylactic agents used for hernia repair prophylaxis. Gentamicin irrigation is also effective in conservative management of hernia mesh infection.[11],[17],[18],[19],[20],[21],[22] Gentamicin is an aminoglycoside and acts by causing misreading of genetic code and inhibiting translocation. Topical delivery of an antibiotic has many potential advantages such as local application causes high concentration at the infection site, limited potential for systemic absorption, and toxicity. In spite of these advantages, topical application of antibiotics has not taken place in guidelines for prophylaxis. The most impressive results were reported by Deysine.[11] He wrote that no infections were observed in thousands of mesh hernioplasties within 25 years in patients whose operative sites were irrigated with a solution of 80 mg gentamicin in conjunction with 1 g preoperative IV cefazolin. The empirical choice of a high concentration gentamicin solution may explain our results.

Probably, the closest study to the present trial was performed by Musella et al.[23] They randomized a large number of cases with mesh repair for inguinal hernias: both groups received IV cephalosporin, the test group was also applied with an absorbable collagen tamponade treated with gentamicin. The test group developed significantly less SSI in comparison with the control group.

Our total SSI rate was only 1.8% with prophylaxis. This infection rate is much lower than the rate of previous study of our clinic. SSI rates were 5% and 7% in prophylaxis and nonprophylaxis groups, respectively. In the previous study, only cefazoline was used as prophylactic agent. This fall in infection rate may be because of obeying more strict aseptic rules such as opening of mesh package just before implantation. In our study, all these three agents acted with same efficiency, there was no difference in SSI among them. Prophylactic antibiotic coverage of mesh hernia repair (by all these three methods) also showed that well-known morbidity factors such as age, BMI, presence of coexisting diseases, and duration of operation did not affect the infection rate and they did not cause any increase in infection ratios. It seems that antibiotic coverage gives surgeon a power to prevent infection even in high-risk patients. Furthermore, type of anesthesia, type of hernia (primary or recurrent) did not show any negative effect on infection rates under prophylaxis coverage.

It seems that, because of conflicting meta-analysis and review reports, so many surgeons are still using prophylactic antibiotics in open mesh hernia repair despite guidelines.

As authors, we believe that the exclusion of incarcerated hernias (emergency surgery) is the only limitation of this study, because it is logic that emergency surgery may need antibiotic coverage more than elective surgery.

According to the results of our study, it seems that usage of IV cefazoline, topical gentamicin, or combination of these is a good alternative with very low SSSI rates and drug safety. Combination prophylaxis seems as more effective method with its zero ratio.


  Conclusion Top


All three methods are equally effective in surgical site infection, but combination method seems better with “0” ratio. Prophlaxy coverage also prevents surgical site infection even in the presence of risk (co-morbidities).

Acknowledgment

All authors willing to thank Can Ates; Research assistant in Ankara University School of Medicine Bio-Statistics Department for his help on statical calculations.

Financial support and sponsorship

Nil.

Conflicts of interest

Dr. Hakan Kulacoglu is an Editorial Board member of International Journal of Abdominal Wall and Hernia Surgery. The article was subject to the journal's standard procedures, with peer review handled independently of this Editorial Board member and their research groups.



 
  References Top

1.
Hill C, Flamant R, Mazas F, Evrard J. Prophylactic cefazolin versus placebo in total hip replacement. Report of a multicentre double-blind randomised trial. Lancet 1981;1:795-6.  Back to cited text no. 1
    
2.
Kaiser AB, Petracek MR, Lea JW 4th, Kernodle DS, Roach AC, Alford WC Jr., et al. Efficacy of cefazolin, cefamandole, and gentamicin as prophylactic agents in cardiac surgery. Results of a prospective, randomized, double-blind trial in 1030 patients. Ann Surg 1987;206:791-7.  Back to cited text no. 2
    
3.
Sanchez-Manuel FJ, Lozano-García J, Seco-Gil JL. Antibiotic prophylaxis for hernia repair. Cochrane Database Syst Rev 2012;2012:CD003769. doi: 10.1002/14651858.  Back to cited text no. 3
    
4.
Simons MP, Aufenacker T, Bay-Nielsen M, Bouillot JL, Campanelli G, Conze J, et al. European Hernia Society guidelines on the treatment of inguinal hernia in adult patients. Hernia 2009;13:343-403.  Back to cited text no. 4
    
5.
HerniaSurge Group. International guidelines for groin hernia management. Hernia 2018;22:1-65.  Back to cited text no. 5
    
6.
Li JF, Lai DD, Zhang XD, Zhang AM, Sun KX, Luo HG, et al. Meta-analysis of the effectiveness of prophylactic antibiotics in the prevention of postoperative complications after tension-free hernioplasty. Can J Surg 2012;55:27-32.  Back to cited text no. 6
    
7.
Yerdel MA, Akin EB, Dolalan S, Turkcapar AG, Pehlivan M, Gecim IE, et al. Effect of single-dose prophylactic ampicillin and sulbactam on wound infection after tension-free inguinal hernia repair with polypropylene mesh: The randomized, double-blind, prospective trial. Ann Surg 2001;233:26-33.  Back to cited text no. 7
    
8.
Esposito S, Leone S, Noviello S, Ianniello F, Marvaso A, Cuniato V, et al. Antibiotic prophylaxis in hernia repair and breast surgery: A prospective randomized study comparing piperacillin/tazobactam versus placebo. J Chemother 2006;18:278-84.  Back to cited text no. 8
    
9.
Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG. CDC definitions of nosocomial surgical site infections, 1992: A modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol 1992;13:606-8.  Back to cited text no. 9
    
10.
Kulacoglu H. Hernia, mesh, and topical antibiotics, especially gentamycin: Seeking the evidence for the perfect outcome. Front Surg 2014;1:53.  Back to cited text no. 10
    
11.
Deysine M. Infection control in a hernia clinic: 24 Year results of aseptic and antiseptic measure implementation in 4,620 “clean cases”. Hernia 2006;10:25-9.  Back to cited text no. 11
    
12.
Yin Y, Song T, Liao B, Luo Q, Zhou Z. Antibiotic prophylaxis in patients undergoing open mesh repair of inguinal hernia: A meta-analysis. Am Surg 2012;78:359-65.  Back to cited text no. 12
    
13.
Mazaki T, Mado K, Masuda H, Shiono M. Antibiotic prophylaxis for the prevention of surgical site infection after tension-free hernia repair: A Bayesian and frequentist meta-analysis. J Am Coll Surg 2013;217:788-8010.  Back to cited text no. 13
    
14.
Ergul Z, Akinci M, Ugurlu C, Kulacoglu H, Yilmaz KB. Prophylactic antibiotic use in elective inguinal hernioplasty in a trauma center. Hernia 2012;16:145-51.  Back to cited text no. 14
    
15.
NICE. 3 Sept 2012. Available from: http://publications.nice.org.uk/surgical-site-infection-cg74/key-priorities-for-implementation [Last accessed on 2019 Nov 14].  Back to cited text no. 15
    
16.
17.
Aiken AM, Haddow JB, Symons NR, Kaptanis S, Katz-Summercorn AC, Debnath D, et al. Use of antibiotic prophylaxis in elective inguinal hernia repair in adults in London and south-east England: A cross-sectional survey. Hernia 2013;17:657-64.  Back to cited text no. 17
    
18.
The Guideline for Prevention of Surgical Site Infection; 1999. Available from : http//www.cdc.gov/hicpac/pdf/SSIguidelines pdf. [Last accessed on 2019 Jul 22].  Back to cited text no. 18
    
19.
Shankar VG, Srinivasan K, Sistla SC, Jagdish S. Prophylactic antibiotics in open mesh repair of inguinal hernia – A randomized controlled trial. Int J Surg 2010;8:444-7.  Back to cited text no. 19
    
20.
Praveen S, Rohaizak M. Local antibiotics are equivalent to intravenous antibiotics in the prevention of superficial wound infection in inguinal hernioplasty. Asian J Surg 2009;32:59-63.  Back to cited text no. 20
    
21.
Usang UE, Sowande OA, Adejuyigbe O, Bakare TI, Ademuyiwa OA. The role of preoperative antibiotics in the prevention of wound infection after day case surgery for inguinal hernia in children in Ile Ife, Nigeria. Pediatr Surg Int 2008;24:1181-5.  Back to cited text no. 21
    
22.
Ruiz-Tovar J, Rey Ibarra A, Devesa Múgica JM. Conservative management of hernia mesh infection. Rev Gastroenterol Peru 2011;31:386-8.  Back to cited text no. 22
    
23.
Musella M, Guido A, Musella S. Collagen tampons as aminoglycoside carriers to reduce postoperative infection rate in prosthetic repair of groin hernias. Eur J Surg 2001;167:130-2.  Back to cited text no. 23
    


    Figures

  [Figure 1]
 
 
    Tables

  [Table 1], [Table 2], [Table 3]



 

Top
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
   Abstract
  Introduction
  Methods
  Results
  Discussion
  Conclusion
   References
   Article Figures
   Article Tables

 Article Access Statistics
    Viewed502    
    Printed2    
    Emailed0    
    PDF Downloaded98    
    Comments [Add]    

Recommend this journal